Running automatic analyzers, computer systems, analytical devices, cooling and freezing units and an HVAC system is very energy consuming. MLM’s current energy consumption corresponds to the demand of fifty four-person-housholds.
MLM is exclusively powered by energy from regenerative sources Read More »
Dr. Rudi Reinards has been co-founder of MLM and has driven the development of MLM for 15 years as managing director. His expertise and his ambition was highly appreciated by clients and company staff members.
Dr. Reinards leaves MLM Read More »
NGSP, www.ngsp.org, is taking care of the harmonisation and comparability of HbA1c data that have been raised by different laboratories with different methods.
MLM has been awarded with NGSP Certification Read More »
In late 2011 MLM has established an advisory board with three very experienced board members: Prof. Dr. Lutz Heinemann, Dr. Jürgen Schumacher and Dr. Theo Stein.
Competent support: MLM Advisory Board Read More »
We are glad to welcome Mrs. Barbara von Buehler who is now taking care of our client’s clinical trials. She is sharing this responsibility with Bettina Vorsprach and Dr. Stephan Voswinkel.
MLM Team now complete again Read More »
Official authorities of North-Rhine-Westphalia, Germany, confirmed MLM’s GLP-compliance by issuing a statement of GLP-compliance in late October 2010. Receiving this certificate MLM is now one of the very few
MLM is a now a certified GLP-lab Read More »
MLM is very happy of now being supported by Mrs. Bettina Vorsprach, a biologist by training. Bettina has joined MLM in April 2010 and is now a very productive member of our team.
MLM’s Team further growing Read More »
MLM is now a CLIA registered lab and therefore has received the permission from the FDA to analyse human samples of blood, serum, plasma and urine. A certification can be performed within two years.
MLM received CLIA certificate Read More »
Early in April 2009 Till Schroer has joined MLM as Clinical Study Director to further strengthen MLM’s competence and performance in supporting clinical trials with laboratory diagnostical and bioanalytical services.
MLM further growing Read More »
For new drug candidates that are potentially affecting the renal function the assessment of the glomerular filtration rate (GFR) and the effective renal plasma flow (ERPF) may be helpful to test nephrotoxicity.
Robust method for iohexol and para-aminohippuric acid analysis in plasma Read More »
